We have investigated an extended pedigree with three cousins affected by Duchenne muscular dystrophy with apparent transmission through the male line. However, molecular studies have shown that one boy has a de novo duplication, another has a deletion, and the molecular mutation has yet to be defined in the third boy. All three X chromosomes in the affected boys appear to have a different origin. We speculate on the mechanisms by which the Duchenne locus may be particularly prone to mutation in this family and the possible involvement of transposons is discussed. Whatever the mechanism involved, the occurrence of three different mutations in one pedigree is a rare event.
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Duchenne muscular dystrophy (DMD) is an X linked recessive neuromuscular disorder with an incidence of 1 in 3000 male live births. The DMD gene has been localised to Xp2l. The disease is associated with a high mutation rate with one-third of cases resulting from new mutations. Affected boys usually die by the age of 20 and the disease is transmitted through non-manifesting carrier females.
The purpose of this report is to present data on a DMD family (fig 1) with three affected cousins. This pedigree came to our attention when the sister (IV.3) of one of the affected boys came for counselling regarding her carrier status. Usually the finding of three affected boys within the same pedigree would suggest the inheritance of a common mutation through carrier females. However, this pedigree is not consistent with the normal female carrier mode of inheritance but may be interpreted as transmission through unaffected males. An alternative explanation is that all three cases have arisen through independent mutations; the chances of this occurring must be very small. We therefore present this as an unusual pedigree. Molecular studies have been carried out to identify the nature of the mutation within the DMD locus in each affected boy and to provide information on the mode of inheritance of the DMD phenotype in this family.
Methods

CLINICAL ASPECTS
The proband (IV.4), now aged 10, complained of pains in his legs, particularly after exercise, from the age of 5 years. It was also noted that he had difficulty in climbing stairs, in rising from the ground, and in running. His school teachers noticed some slowness in learning. Examination at 51 years showed moderate weakness of the pectoral and quadriceps muscles, large calves, and a positive Gower's sign. Ankle reflexes were depressed. The creatine kinase level was 25 711 IU/1. A muscle biopsy showed early dystrophic process with necrosis, regeneration, hyaline fibres, and a minor degree of fibre type grouping. Electromyography showed an occasional myopathic unit in the quadriceps. DNA was fractionated using the 'Waltzer' apparatus5 on 1-5% agarose (Sigma type II) gels in 0-5 x TAE (0-02 mol/l Tris acetate, 0.01 mol/l EDTA) buffer. Gels were run for 32 hours at 150 V with a pulse time of 60 seconds, buffer temperature 19°C. After electrophoresis, gels were depurinated (0-2 mol/l NaOH), denatured (0-25 N HCI), and DNA was transferred to Genescreen Plus nylon membrane (Du Pont) according to the manufacturer's instructions. Filters were hybridised at 65°C in 0 5 mol/l sodium phosphate, pH 7 5, 7% SDS, J-Bir P20 pERT87-1 In approximately 60% of Duchenne and Becker cases the molecular basis of the mutation giving rise to the disease phenotype has been shown to be the result of the deletion of sequences within the DMD gene.3 6 The majority of the deletions lie within an area defined by the two contiguous probes Cf56a and Cf56b and the genomic clone P20 lies within an intron between two exons encompassed by Cf56b. DNA from IV.2 failed to hybridise with the clone P20 although all other probes gave positive signals. Neither of his two affected cousins were deleted for any probe used. Further analysis using the cDNA probes Cf56a and Cf56b was undertaken to determine the extent of the deletion in subject IV.2 and to search for possible deletions in the other two affected boys (IV.1 and IV.4). No deletions were detected in any family members with Cf56a. Fig 3 shows the hybridisation pattern seen with Cf56b. Subject IV.2 has a deletion of the 38 kb fragment represented by exon F, which is consistent with the observed P20 deletion, since this sequence lies in the adjacent intron. The 15 kb fragment representing fragment C is also absent although an additional band of 20 kb is present. This is thought to be a rare PstI polymorphism which has been reported elsewhere.7 This same polymorphism is seen in the boy's mother (III.4). Table 2 lists the probes hybridised to the family members. XJ l. 1 maps to an 690 kb and 840 kb partial digestion fragment. The adjacent probe pERT87 -1 maps to a single 250 kb fragment. The most distal probes used, J-Bir and P20, both map to the same 500 kb fragment and also detect a 620 kb partial digestion fragment. In all family members tested, XJl1.1 identified the 840 kb and 690 kb bands; however, patient IV.4 alone had an additional 230 kb band. same SfiI fragment as J-Bir. The result was a complete P20 deletion in patient IV.2 and this is consistent with the Cf56b deletion detected in this patient, as this probe maps to the same SfiI fragment as P20. Unfortunately, blood was not available from the patient's mother (III.4) for pulsed field studies.
The normal hybridisation signals for patient IV. 1 with the probes J-Bir and XJ1.1 indicate that whatever the mutation, it is different from that of his two cousins.
Discussion
Mutations within the DMD locus have been shown in two of the three affected boys in this pedigree. Patient IV.4 has a duplication and patient IV.2 a deletion within the dystrophin gene. As yet, no mutation has been defined in the third affected boy, IV.1. The Duchenne phenotype is therefore the result of a different mutational event in each affected boy.
The XJ1.1 duplication was not detected in either parent of IV.4. The usual conclusion would therefore be that this duplication has arisen as a de novo event. In a study of 120 ous unrelated DMD and BMD boys, a frequency rns D of 7 5% for duplications was reported.8 However, the possibility that the boy's mother has germline or somatic cell mosaicism for the Miciak 
